These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 659873)

  • 1. Studies on the terminal stages of immune hemolysis. III. Distinction between the insertion of C9 and the formation of a transmembrane channel.
    Boyle MD; Langone JJ; Borsos T
    J Immunol; 1978 May; 120(5):1721-25. PubMed ID: 659873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.
    Hammer CH; Shin ML; Abramovitz AS; Mayer MM
    J Immunol; 1977 Jul; 119(1):1-8. PubMed ID: 559700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinction between C8-mediated and C8/C9-mediated hemolysis on the basis of independent 86Rb and hemoglobin release.
    Gee AP; Boyle MD; Borsos T
    J Immunol; 1980 Apr; 124(4):1905-10. PubMed ID: 7365242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the terminal stages of immune hemolysis. IV. Effect of metal salts.
    Boyle MD; Langone JJ; Borsos T
    J Immunol; 1979 Apr; 122(4):1209-13. PubMed ID: 448086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
    Hu VW; Shin ML
    J Immunol; 1984 Oct; 133(4):2133-7. PubMed ID: 6470486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of complement-induced cell lysis. Demonstration of a three-step mechanism of EAC1-8 cell lysis by C9 and of a non-osmotic swelling of erythrocytes.
    Valet G; Opferkuch W
    J Immunol; 1975 Oct; 115(4):1028-33. PubMed ID: 809505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the C9b domain in the binding of C9 molecules to EAC1-8 defined by monoclonal antibodies to C9.
    Yoden A; Moriyama T; Inoue K; Inai S
    J Immunol; 1988 Apr; 140(7):2317-21. PubMed ID: 3351301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modifications of the final stages of the complement reaction by alkali metal cations.
    Dalmasso AP; Lelchuk R; Giavedoni EB; De Isola ED
    J Immunol; 1975 Jul; 115(1):63-8. PubMed ID: 239058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the terminal stages of immune hemolysis. V. Evidence that not all complement-produced transmembrane channels are equal.
    Boyle MD; Borsos T
    J Immunol; 1979 Jul; 123(1):71-6. PubMed ID: 109540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The attack phase of human complement: differentiation between membrane binding and complex formation by the detection of neoantigen expression in situ. A morphometric immunoferritin study.
    Balkarowa-Ständer J; Rother U; Rauterberg EW
    J Immunol; 1981 Sep; 127(3):1089-93. PubMed ID: 7264298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement lysis: evidence for an amphiphilic nature of the terminal membrane C5b-9 complex of human complement.
    Bhakdi S; Bjerrum OJ; Bhakdi-Lehnen B; Tranum-Jensen J
    J Immunol; 1978 Dec; 121(6):2526-32. PubMed ID: 569173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restriction of cell lysis by homologous complement: II. Protection of erythrocytes against lysis by newly activated complement.
    Houle JJ; Hoffmann EM; Esser AF
    Blood; 1988 Feb; 71(2):287-92. PubMed ID: 3337897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3-independent immune haemolysis: mechanism of membrane attack complex formation.
    Kitamura H; Tsuboi M; Nagaki K
    Immunology; 1986 Sep; 59(1):147-51. PubMed ID: 3759127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes.
    Hammer CH; Nicholson A; Mayer MM
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):5076-80. PubMed ID: 1061092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric horse/human recombinant C9 proteins identify the amino acid sequence in horse C9 responsible for restriction of hemolysis.
    Tomlinson S; Wang Y; Ueda E; Esser AF
    J Immunol; 1995 Jul; 155(1):436-44. PubMed ID: 7541424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane fluidity change in erythrocytes induced by complement system.
    Nakamura M; Ohnishi S; Kitamura H; Inai S
    Biochemistry; 1976 Nov; 15(22):4838-43. PubMed ID: 186096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
    Tomlinson S; Whitlow MB; Nussenzweig V
    J Immunol; 1994 Feb; 152(4):1927-34. PubMed ID: 7509832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative measurement of C9 sites and their association to the ring-like "lesions" on complementlysed membranes: a morphometric immunoferritin study.
    Rauterberg EW; Ungemach B; Gebest HJ
    J Immunol; 1979 Jan; 122(1):355-65. PubMed ID: 570204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.